FENNEC PHARMACEUTICALS INC (FENC)

CA31447P1009 - Common Stock

9.09  0 (0%)

After market: 9.54 +0.45 (+4.95%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

 2023
(2023-12-31)		 2022
(2022-12-31)		 2021
(2021-12-31)		 2020
(2020-12-31)		 2019
(2019-12-31)
ASSETS
Current Assets
Cash
1.34MN/AN/AN/AN/A
Cash Equivalents
11.93M23.77M21.10M30.34M13.65M
Receivables
8.81M1.55MN/AN/AN/A
Inventories
2.16M580.00KN/AN/AN/A
Other Current Assets
2.62M830.00K1.28M1.08M240.00K
Total Current Assets
26.86M26.73M22.39M31.42M13.88M
 
Non-Current Assets
Other Non-Current Assets
6.00K210.00K30.00K0.00260.00K
Total Non-Current Assets
6.00K210.00K20.00K0.00270.00K
 
TOTAL ASSETS
26.86M26.94M22.41M31.42M14.15M
 
LIABILITIES
Current Liabilities
Short Term Debt
0.000.000.000.000.00
Accrued Expenses
3.77M2.22M880.00K780.00K660.00K
Accounts Payable
3.78M2.39M780.00K1.57M1.61M
Other Current Liabilities
N/AN/AN/AN/AN/A
Total Current Liabilities
7.55M4.61M1.65M2.35M2.27M
 
Non-Current Liabilities
Long Term Debt
30.00M25.00M5.00M0.000.00
Other Non-Current Liabilities
933.00K-100.00K-10.00KN/AN/A
Total Non-Current Liabilities
30.93M24.90M4.99M0.000.00
 
TOTAL LIABILITIES
38.49M29.51M6.64M2.35M2.27M
 
SHAREHOLDERS' EQUITY
Retained Earnings
-219.25M-203.20M-179.49M-162.14M-144.03M
Additional Paid In Capital
62.07M56.80M53.21M49.23M48.27M
Common Shares
144.31M142.59M140.80M140.73M106.39M
Other Shareholders' Equity
1.24M1.24M1.24M1.24M1.24M
Shares Outstanding
27.03M26.36M26.01M26.00M19.90M
Tangible Book Value per Share
-0.43-0.100.611.120.60
Total Shareholders' Equity
-11.62M-2.57M15.77M29.07M11.88M
 
TOTAL LIABILITIES AND EQUITY
26.86M26.94M22.41M31.42M14.15M
 
Statistics
Debt/Equity
-2.58-9.730.32N/AN/A
Current Ratio
3.565.8013.5713.376.11
Return On Assets (ROA)
-59.73%-88.01%-77.42%-57.64%-90.32%
Return On Equity (ROE)
N/AN/A-110.02%-62.30%-107.58%

All data in USD

Charts